Indeed, adoptive transfer of iNKT cells activated in vitro with a combination of IL-12 and IL-18 robustly produces IL-2 and IFN-γ, which in turn activates NK cells to mediate anti-tumor response in vivo [34]. The gene discussed is IL18; the disease is neoplasm.